IL106521A0 - Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure - Google Patents

Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure

Info

Publication number
IL106521A0
IL106521A0 IL106521A IL10652193A IL106521A0 IL 106521 A0 IL106521 A0 IL 106521A0 IL 106521 A IL106521 A IL 106521A IL 10652193 A IL10652193 A IL 10652193A IL 106521 A0 IL106521 A0 IL 106521A0
Authority
IL
Israel
Prior art keywords
prevention
treatment
pharmaceutical composition
intraocular pressure
elevated intraocular
Prior art date
Application number
IL106521A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL106521A0 publication Critical patent/IL106521A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL106521A 1992-07-31 1993-07-29 Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure IL106521A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216380A GB9216380D0 (en) 1992-07-31 1992-07-31 Medicaments

Publications (1)

Publication Number Publication Date
IL106521A0 true IL106521A0 (en) 1993-11-15

Family

ID=10719673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106521A IL106521A0 (en) 1992-07-31 1993-07-29 Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure

Country Status (8)

Country Link
US (1) US5693654A (fr)
EP (1) EP0655912A1 (fr)
JP (1) JPH07509476A (fr)
AU (1) AU4705193A (fr)
GB (1) GB9216380D0 (fr)
IL (1) IL106521A0 (fr)
WO (1) WO1994003162A1 (fr)
ZA (1) ZA935522B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (fr) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. Utilisation d'agonistes de 5-ht1b/1d dans le traitement de douleurs oculaires
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
JP2002526443A (ja) 1998-09-18 2002-08-20 アルコン ラボラトリーズ， インコーポレーテッド 緑内障治療用セロトニン作動性５ｈｔ２作用物質
AU2001216035A1 (en) * 2000-03-17 2001-10-03 Alcon Universal Ltd. 5-hydroxy indole derivatives for treating glaucoma
US6806285B1 (en) 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
DE60117247D1 (de) * 2000-03-31 2006-04-20 Purdue Research Foundation West Lafayette Phosphoramidat-prodrugs
US7005448B2 (en) * 2001-12-14 2006-02-28 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
MXPA05006277A (es) 2002-12-13 2005-09-08 Alcon Inc Analogos de benzopirano novedosos y su uso para el tratamiento de glaucoma.
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
WO2007149728A2 (fr) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Dérivés d'aryl et d'hétéroaryl tétrahydrobenzazépine et leur utilisation pour traiter le glaucome

Also Published As

Publication number Publication date
WO1994003162A1 (fr) 1994-02-17
AU4705193A (en) 1994-03-03
JPH07509476A (ja) 1995-10-19
US5693654A (en) 1997-12-02
EP0655912A1 (fr) 1995-06-07
GB9216380D0 (en) 1992-09-16
ZA935522B (en) 1994-06-13

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
AU4859793A (en) Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
HU9602671D0 (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
IL117655A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
AU1188492A (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL105285A0 (en) Compositions for the treatment of diabetes
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
EP0564216A3 (en) Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
EP0653208A3 (fr) Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv